Advertisement

Factors Associated With Receipt of Meningococcal B Vaccine Among United States Adolescents, National Immunization Survey-Teen, 2017–2018

      Abstract

      Purpose

      In this study, we evaluated factors associated with receipt of meningococcal serogroup B (MenB) vaccine among adolescents in the United States.

      Methods

      We used public use data files from the National Immunization Survey-Teen from 2017 to 2018. Logistic regression was used to model associations among sociodemographic, healthcare, and vaccination variables of interest and MenB vaccine receipt (≥1 vs. 0 dose). To explore associations between state-level meningococcal vaccination requirements and MenB vaccine uptake, we performed a secondary analysis stratified by presence of a quadrivalent meningococcal (MenACWY) vaccination requirement for secondary school attendance in the adolescent’s state of residence (no requirement vs. a one- or two-dose requirement).

      Results

      Among 7,288 adolescents, MenB vaccine receipt was significantly associated with up-to-date human papillomavirus (adjusted odds ratio [aOR] 1.74, 95% confidence interval [CI] 1.29–2.35) and MenACWY (aOR 5.81, 95% CI 4.14–8.13) vaccination status in multivariable analysis. Adolescents with private insurance were less likely to be vaccinated (aOR .61, 95% CI .46–.79) compared to adolescents with other health insurance types. In secondary analyses, health insurance was no longer significantly associated with MenB vaccine uptake among adolescents in states with a MenACWY requirement.

      Conclusions

      We found that MenB vaccination is associated with receipt of other vaccines recommended for use in adolescents. Adolescents with private health insurance were less likely to be vaccinated against MenB, although state MenACWY requirements appeared to modify the effect of insurance on MenB vaccine receipt. Further work to understand how these factors may influence delivery and acceptance of MenB vaccine can inform interventions and strategies to improve uptake.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Adolescent Health
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Wang B.
        • Santoreneos R.
        • Giles L.
        • et al.
        Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis.
        Vaccine. 2019; 37: 2768-2782
        • Martinon-Torres F.
        Deciphering the burden of meningococcal disease: Conventional and under-recognized elements.
        J Adolesc Health. 2016; 59: S12-S20
        • MacNeil J.R.
        • Rubin L.
        • Folaranmi T.
        • et al.
        Use of serogroup B meningococcal vaccines in adolescents and young adults: Recommendations of the Advisory Committee on immunization practices, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1171-1176
        • Marshall G.S.
        • Dempsey A.F.
        • Srivastava A.
        • Isturiz R.E.
        US college students are at increased risk for serogroup B meningococcal disease.
        J Pediatr Infect Dis Soc. 2019; 9: 244-247
        • Mbaeyi S.A.
        • Joseph S.J.
        • Blain A.
        • et al.
        Meningococcal disease among college-aged young adults: 2014-2016.
        Pediatrics. 2019; 143: e20182130
      1. CDC. ACIP shared clinical decision-making recommendations. Available at: https://www.cdc.gov/vaccines/acip/acip-scdm-faqs.html. Published February 2020. Accessed June 22, 2020.

        • Walker T.Y.
        • Elam-Evans L.D.
        • Yankey D.
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 718-723
        • Elam-Evans L.D.
        • Yankey D.
        • Singleton J.A.
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2019.
        MMWR Morb Mortal Wkly Rep. 2020; 69: 1109-1116
        • U.S. Department of Health and Human Services (DHHS)
        National Center for Immunization and Respiratory Diseases. The 2017 National Immunization Survey - Teen.
        Centers for Disease Control and Prevention, Atlanta, GA2018
        • U.S. Department of Health and Human Services (DHHS)
        National Center for Immunization and Respiratory Diseases. The 2018 National Immunization Survey - Teen.
        Centers for Disease Control and Prevention, Atlanta, GA2020
        • Kepka D.
        • Ding Q.
        • Hawkins A.J.
        • et al.
        Factors associated with early adoption of the HPV vaccine in US male adolescents include Hispanic ethnicity and receipt of other vaccines.
        Prev Med Rep. 2016; 4: 98-102
        • Perkins R.B.
        • Brogly S.B.
        • Adams W.G.
        • Freund K.M.
        Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: A multicenter study.
        J Womens Health (Larchmt). 2012; 21: 813-820
        • Tiro J.A.
        • Pruitt S.L.
        • Bruce C.M.
        • et al.
        Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics.
        Vaccine. 2012; 30: 2368-2375
        • Niccolai L.M.
        • Yakely A.E.
        • Hansen C.E.
        Up-to-date coverage with meningococcal vaccine among adolescents age 17 years: Patterns and correlates in the United States, 2017.
        Vaccine. 2019; 37: 5934-5938
        • Moss J.L.
        • Reiter P.L.
        • Truong Y.K.
        • et al.
        School entry requirements and coverage of nontargeted adolescent vaccines.
        Pediatrics. 2016; 138: e20161414
        • Immunization Action Coalition
        MenACWY vaccine mandates for elementary and secondary schools.
        (Available at:) (Published November 2019. Accessed May 5, 2020)
        • Centers for Disease Control and Prevention
        NIS-Teen data and documentation for 2015 to present.
        (Available at:) (Published January 2020. Accessed December 1, 2020)
        • Huang L.
        • Goren A.
        • Lee L.K.
        • et al.
        Disparities in healthcare providers’ interpretations and implementations of ACIP’s meningococcal vaccine recommendations.
        Hum Vaccin Immunother. 2020; 16: 933-944
        • Walker T.Y.
        • Elam-Evans L.D.
        • Yankey D.
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2017.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 909-917
        • Dorell C.
        • Yankey D.
        • Jeyarajah J.
        • et al.
        Delay and refusal of human papillomavirus vaccine for girls, National immunization Survey-Teen, 2010.
        Clin Pediatr (Phila). 2014; 53: 261-269
        • Healy C.M.
        • Montesinos D.P.
        • Middleman A.B.
        Parent and provider perspectives on immunization: Are providers overestimating parental concerns?.
        Vaccine. 2014; 32: 579-584
        • Srivastava A.
        • Dempsey A.
        • Galitsky A.
        • et al.
        Parental awareness and utilization of meningococcal serogroup B vaccines in the United States.
        BMC Public Health. 2020; 20: 1109
        • Morita J.Y.
        • Ramirez E.
        • Trick W.E.
        Effect of a school-entry vaccination requirement on racial and ethnic disparities in hepatitis B immunization coverage levels among public school students.
        Pediatrics. 2008; 121: e547
        • Kharbanda E.O.
        • Stockwell M.S.
        • Colgrove J.
        • et al.
        Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade.
        Am J Public Health. 2010; 100: 1635
        • Oliver S.E.
        • Patton M.E.
        • Hoban M.
        • et al.
        Evaluation of meningococcal vaccination policies among colleges and universities - United States, 2017.
        J Am Coll Health. 2019; : 1-6https://doi.org/10.1080/07448481.2019.1687484
        • Meningitis B Action Project
        Meningitis B vaccination school mandate tracker.
        (Available at:) (Published June 2020. Accessed December 2, 2020)
        • Bernstein H.H.
        • Bocchini Jr., J.A.
        • Committee on Infectious Diseases
        The need to optimize adolescent immunization.
        Pediatrics. 2017; 139: e20164186
        • Kempe A.
        • Allison M.A.
        • MacNeil J.R.
        • et al.
        Knowledge and attitudes regarding category B ACIP recommendations among primary care providers for children.
        Acad Pediatr. 2018; 18: 763-768
        • Kempe A.
        • Allison M.A.
        • MacNeil J.R.
        • et al.
        Adoption of serogroup B meningococcal vaccine recommendations.
        Pediatrics. 2018; 142: e20180344
        • Committee on Infectious Diseases
        Recommendations for serogroup B meningococcal vaccine for persons 10 years and older.
        Pediatrics. 2016; 138: e20161890
        • Watkins E.
        • Feemster K.
        Factors associated with uptake of meningococcus B vaccination after an ACIP category B recommendation.
        Open Forum Infect Dis. 2018; 5: S737